The Daily Buyout
$273M revenueMergerHealthcare & Life Sciences

Telix to Merge With Germany's ITM in Radiopharmaceutical Tie-Up

Telix Pharmaceuticals signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich, a private radioisotope producer that reported US$273 million of 2025 revenue.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

More Healthcare & Life Sciences deals